Literature DB >> 10597287

Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro.

H Li1, Y Cao, M C Berndt, J W Funder, J P Liu.   

Abstract

The telomere DNA polymerase (telomerase) and the tumor suppressor protein p53 are frequently associated with human cancers, and activation of telomerase and inactivation of p53 involved in cancer cell immortalization. In this report, we demonstrate a direct interaction of telomerase with p53 in the nuclear lysates of human breast cancer cells, and with recombinant human p53, by affinity chromatography and immunoprecipitation. On activity criteria, the interaction is between the carboxyl-terminal region of p53 and a region close to the amino-terminus of human telomerase-associated protein 1 (hTEP1). Incubation of recombinant p53 with nuclear telomerase extracts results in inhibition of telomerase activity, with the C-terminal region of p53 being essential for inhibition. This effect is not mediated by binding to telomerase substrate DNA, but requires the region near the N-terminus of hTEP1, in that a synthetic peptide derived from this region of hTEP1 similarly inhibits telomerase activity. Together, these in vitro interactions between telomerase and p53 suggest that the activity of telomerase may be regulated by p53, down-regulation of which in turn would favor up-regulation of telomerase activity in cancer cell development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597287     DOI: 10.1038/sj.onc.1203061

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function.

Authors:  W Fu; M Killen; C Culmsee; S Dhar; T K Pandita; M P Mattson
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

Review 2.  Telomerase: biological function and potential role in cancer management.

Authors:  V D Chatziantoniou
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 3.  Complex regulation of telomerase activity: implications for cancer therapy.

Authors:  K S Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc.

Authors:  L Gewin; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Essential role for the interaction between hnRNP H/F and a G quadruplex in maintaining p53 pre-mRNA 3'-end processing and function during DNA damage.

Authors:  Adrien Decorsière; Anne Cayrel; Stéphan Vagner; Stefania Millevoi
Journal:  Genes Dev       Date:  2011-02-01       Impact factor: 11.361

6.  Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia.

Authors:  Enrica Rampazzo; Engin Bojnik; Livio Trentin; Laura Bonaldi; Paola Del Bianco; Federica Frezzato; Andrea Visentin; Monica Facco; Gianpietro Semenzato; Anita De Rossi
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

7.  Telomerase expression in amyotrophic lateral sclerosis (ALS) patients.

Authors:  Bruna De Felice; Anna Annunziata; Giuseppe Fiorentino; Francesco Manfellotto; Raffaella D'Alessandro; Rita Marino; Marco Borra; Elio Biffali
Journal:  J Hum Genet       Date:  2014-08-21       Impact factor: 3.172

Review 8.  Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.

Authors:  Rita Nahta; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Rafaela Andrade-Vieira; Sarah N Bay; Dustin G Brown; Gloria M Calaf; Robert C Castellino; Karine A Cohen-Solal; Annamaria Colacci; Nichola Cruickshanks; Paul Dent; Riccardo Di Fiore; Stefano Forte; Gary S Goldberg; Roslida A Hamid; Harini Krishnan; Dale W Laird; Ahmed Lasfar; Paola A Marignani; Lorenzo Memeo; Chiara Mondello; Christian C Naus; Richard Ponce-Cusi; Jayadev Raju; Debasish Roy; Rabindra Roy; Elizabeth P Ryan; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Renza Vento; Jan Vondráček; Mark Wade; Jordan Woodrick; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

9.  Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents.

Authors:  Z Lin; S Lim; M A Viani; M Sapp; M S Lim
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 10.  Telomeres-structure, function, and regulation.

Authors:  Weisi Lu; Yi Zhang; Dan Liu; Zhou Songyang; Ma Wan
Journal:  Exp Cell Res       Date:  2012-09-21       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.